| Recent changes for Paracetamol |
|---|
| Date | Field | Changed From | Changed To |
|---|
| 30th October 2024 | Notes | Please note: from the 30/10/2024 Paracetamol is reported in mg/L.
The protocol for treatment held in the Emergency Department should be studied and followed.
NOTE: Lower levels may be toxic in chronic users and patients with certain co-morbidities.
Alfred Health - Please refer to PROMPT guideline: MEDICATION GUIDELINE: ACETYLCYSTEINE (NAC) INFUSION
Nomogram
| Please note: from the 30/10/2024 Paracetamol is reported in mg/L.
The protocol for treatment held in the Emergency Department should be studied and followed.
NOTE: Lower levels may be toxic in chronic users and patients with certain co-morbidities.
Alfred Health - Please refer to PROMPT guideline: MEDICATION GUIDELINE: ACETYLCYSTEINE (NAC) INFUSION
|
| 30th October 2024 | Notes | Please note: from the 30/10/2024 Paracetamol is reported in mg/L.
The protocol for treatment held in the Emergency Department should be studied and followed.
NOTE: Lower levels may be toxic in chronic users and patients with certain co-morbidities.
Alfred Health - PROMPT guideline
MJA Paractemol Consensus Statement.
| Please note: from the 30/10/2024 Paracetamol is reported in mg/L.
The protocol for treatment held in the Emergency Department should be studied and followed.
NOTE: Lower levels may be toxic in chronic users and patients with certain co-morbidities.
Alfred Health - Please refer to PROMPT guideline: MEDICATION GUIDELINE: ACETYLCYSTEINE (NAC) INFUSION
Nomogram
|
| 30th October 2024 | Notes | The protocol for treatment held in the Emergency Department should be studied and followed.
NOTE: Lower levels may be toxic in chronic users and patients with certain co-morbidities.
Nomogram
MJA Paractemol Consensus Statement.
| Please note: from the 30/10/2024 Paracetamol is reported in mg/L.
The protocol for treatment held in the Emergency Department should be studied and followed.
NOTE: Lower levels may be toxic in chronic users and patients with certain co-morbidities.
Alfred Health - PROMPT guideline
MJA Paractemol Consensus Statement.
|
| 20th August 2024 | Notes | The protocol for treatment held in the Emergency Department should be studied and followed.
NOTE: Lower levels may be toxic in chronic users and patients with certain co?morbidities.
Nomogram
MJA Paractemol Consensus Statement.
| The protocol for treatment held in the Emergency Department should be studied and followed.
NOTE: Lower levels may be toxic in chronic users and patients with certain co-morbidities.
Nomogram
MJA Paractemol Consensus Statement.
|
| 20th August 2024 | Preferred Specimen Type | Serum
Plasma | Blood |
| Optional Container Type | | SST |
| Collection & Request Instructions | Patients with potentially toxic concentrations are in danger of serious complications, especially liver damage, which may not become apparent for 2—4 days.
Specimen must be collected at least four (4) hours post-ingestion. | Patients with potentially toxic concentrations are in danger of serious complications, especially liver damage, which may not become apparent for 2—4 days.
Specimen must be collected at least four (4) hours post-ingestion. |
| Notes | The protocol for treatment held in the Emergency Department should be studied and followed.
NOTE: Lower levels may be toxic in chronic users and patients with certain co‑morbidities.
Nomogram
MJA Paractemol Consensus Statement.
| The protocol for treatment held in the Emergency Department should be studied and followed.
NOTE: Lower levels may be toxic in chronic users and patients with certain co?morbidities.
Nomogram
MJA Paractemol Consensus Statement.
|